Survival of patients with metastatic leiomyosarcoma: the MD Anderson Clinical Center for targeted therapy experience-Reference-Cited by-同舟云学术

Survival of patients with metastatic leiomyosarcoma: the MD Anderson Clinical Center for targeted therapy experience

Published:2016-11-23 Issue:12 Volume:5 Page:3437-3444
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Wang Zhijie¹²,Shi Naiyi¹,Naing Aung¹,Janku Filip¹,Subbiah Vivek¹,Araujo Dejka M.³,Patel Shreyaskumar R.³,Ludwig Joseph A.³,Ramondetta Lois M.⁴,Levenback Charles F.⁴,Ramirez Pedro T.⁴,Piha-Paul Sarina A.¹,Hong David¹,Karp Daniel D.¹,Tsimberidou Apostolia M.¹,Meric-Bernstam Funda¹,Fu Siqing¹

Affiliation:

1. Department of Investigational Cancer Therapeutics; The University of Texas MD Anderson Cancer Center; Houston Texas

2. Department of Medical Oncology; Cancer Hospital; Chinese Academy of Medical Sciences & Peking Union Medical College; Beijing China

3. Department of Sarcoma Medical Oncology; The University of Texas MD Anderson Cancer Center; Houston Texas

4. Department of Gynecologic Oncology and Reproductive Medicine; The University of Texas MD Anderson Cancer Center; Houston Texas

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Reference41 articles.

1. Diagnosis, prognosis, and management of leiomyosarcoma: recognition of anatomic variants;Bathan;Curr. Opin. Oncol.,2013

2. Leiomyosarcoma;Serrano;Hematol. Oncol. Clin. North Am.,2013

3. Uterine leiomyosarcoma: a review article;Gockley;Int. J. Gynecol. Cancer,2014

4. Prognostic factors in patients with recurrent or metastatic retroperitoneal leiomyosarcoma;Li;Future Oncol.,2015

5. Extremity leiomyosarcoma metastasizing to the large bowel as a pedunculated colon polyp;Ipach;J. Clin. Oncol.,2011

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Heterogeneity in Leiomyosarcoma and Implications for Personalised Medicine;Current Treatment Options in Oncology;2024-04-24

2. Case report: Highly response to low-dose brachytherapy in recurrent retroperitoneal leiomyosarcoma with FANCD2 frameshift mutation: a unique case study;Frontiers in Oncology;2024-04-03

3. PD-1 Inhibition in metastatic high tumour mutational burden (TMB) leiomyosarcoma with clinicopathological correlates;BMJ Case Reports;2023-11

4. Novel metabolomics-biohumoral biomarkers model for predicting survival of metastatic soft-tissue sarcomas;iScience;2023-10

5. B-cell lymphoma 2 family members and sarcomas: a promising target in a heterogeneous disease;Exploration of Targeted Anti-tumor Therapy;2023-08-24